New Ray Medicine International Holding Limited reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was HKD 73.04 million compared to HKD 59.29 million a year ago. Net loss was HKD 13.36 million compared to HKD 21.38 million a year ago.

Basic loss per share from continuing operations was HKD 0.008 compared to HKD 0.0128 a year ago.